Weybridge, United Kingdom

Carl Sterritt

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Carl Sterritt

Introduction

Carl Sterritt is a notable inventor based in Weybridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the administration of treprostinil. With a total of 5 patents to his name, Sterritt's work has enhanced the quality of life for many patients.

Latest Patents

One of Sterritt's latest patents focuses on the administration of treprostinil by inhalation. This innovative method allows treprostinil to be delivered using a metered dose inhaler, providing patients with a greater degree of autonomy. Additionally, the patent includes kits that feature a metered dose inhaler containing a pharmaceutical formulation of treprostinil. This advancement represents a significant step forward in patient care.

Career Highlights

Sterritt is currently associated with United Therapeutics Corporation, a company dedicated to advancing the treatment of chronic and life-threatening conditions. His work at United Therapeutics has been instrumental in developing new therapeutic options for patients.

Collaborations

Throughout his career, Sterritt has collaborated with esteemed colleagues such as Horst Olschewski and Robert Roscigno. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Carl Sterritt's contributions to the field of pharmaceuticals, particularly through his patents on treprostinil administration, highlight his commitment to improving patient care. His work continues to inspire advancements in medical technology and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…